Information about Batavia Biopharma
My details
*
*
*

Batavia Biopharma (BV)

NL

27360045

Company information

Status
Active

KVK number

27360045

VAT Number

NL 821465132 B01
Established
06-11-2009
Last balance sheet year
2025
Company size
Medium-sized 0 FTE
Legal form
Besloten Vennootschap (BV)
RSIN number
821465132
Principal activity
Activities of organisational consultancy firms
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Batavia Biopharma

2025 2024 2023 2022
Balance sheet
Balance sheet total € 1.091.753 -62% € 2.866.924 -72% € 10.163.554 -21% € 12.827.779
Equity € 229.841 -92% € 2.863.941 -72% € 10.162.049 -21% € 12.814.729
Debts € 861.912 > 1000% € 2.983 98% € 1.505 -88% € 13.050
Other
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Batavia Biopharma?
The KVK number of Batavia Biopharma is 27360045
What is the VAT number of Batavia Biopharma?
The VAT number of Batavia Biopharma is NL 821465132 B01.
Wat is the PEPPOL ID of Batavia Biopharma?
There is no information available about the PEPPOL ID of Batavia Biopharma or the company is not yet registered on the PEPPOL network.
When was Batavia Biopharma founded?
Batavia Biopharma was founded on 06-11-2009.
What is the address of Batavia Biopharma?
The current registered office of Batavia Biopharma is located at Sportveldweg 21, 2151 CA Nieuw Vennep.
When was the last time Batavia Biopharma filed their annual financial statements?
The most recent financial statements of Batavia Biopharma were filed on 31-12-2025.
How many employees does Batavia Biopharma have?
There are currently no employees working at Batavia Biopharma or no workforce information is available.
What is the annual turnover of Batavia Biopharma?
There is no turnover available for Batavia Biopharma.

Sources